戻る Agenda
[V7-S5] Introduction to database study II - Example for RMP
Session Chair(s)
Chieko Ishiguro, PHD, MPH
Section Chief of Clinical Epidemiology, Department of Data Science
National Center for Global Health and Medicine, Japan
Rei Maeda
Consultant
Independent Consultant for Drug PV, Japan
Database studies based on secondary data analysis of automated largescale health care databases, such as claims data and electronic medical records, have been widely acknowledged and employed in postmarketing evaluations overseas. This session will outline and discuss the current issues and challenges in fully introducing and quickly realizing database studies in Japan.
Speaker(s)
Post Expected to RMP of DB Research - 2017, 2018
Kotonari Aoki, MS
Chugai Pharmaceutical Co., Ltd., Japan
Head of Real World Data Science Dept. Drug Safety Div.
Approach for Utilization of Medical DB
Kasumi Daidoji, PHD, RPH
Eisai Company, Ltd., Japan
Associate Director, Clinical Planning & Development Dept., Medical Headquarters
Case Control Ctudy Design in Point of View of Cohort Study
Tatsuo Kagimura, MPH
Translational Research Informatics Center (TRI), Japan
Chief, Department of Analysis
Gerald Dal Pan, MD, MHS
FDA, United States
Director, Office of Surveillance and Epidemiology, CDER